Henry Schein, Inc. $HSIC Position Increased by Cetera Investment Advisers

Cetera Investment Advisers boosted its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 14.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,924 shares of the company’s stock after acquiring an additional 630 shares during the quarter. Cetera Investment Advisers’ holdings in Henry Schein were worth $337,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Guggenheim Capital LLC boosted its position in shares of Henry Schein by 2.5% in the fourth quarter. Guggenheim Capital LLC now owns 6,428 shares of the company’s stock worth $445,000 after buying an additional 159 shares during the period. UMB Bank n.a. boosted its position in Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company’s stock valued at $73,000 after purchasing an additional 201 shares during the last quarter. Humankind Investments LLC boosted its position in Henry Schein by 7.4% during the fourth quarter. Humankind Investments LLC now owns 3,057 shares of the company’s stock valued at $212,000 after purchasing an additional 211 shares during the last quarter. J. Safra Sarasin Holding AG boosted its position in Henry Schein by 1.1% during the fourth quarter. J. Safra Sarasin Holding AG now owns 22,098 shares of the company’s stock valued at $1,529,000 after purchasing an additional 231 shares during the last quarter. Finally, Allworth Financial LP boosted its position in Henry Schein by 24.5% during the first quarter. Allworth Financial LP now owns 1,178 shares of the company’s stock valued at $78,000 after purchasing an additional 232 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Evercore ISI reduced their price objective on Henry Schein from $78.00 to $70.00 and set an “in-line” rating for the company in a research report on Wednesday, August 6th. Robert W. Baird reiterated a “neutral” rating and issued a $72.00 target price (down from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Stifel Nicolaus restated a “hold” rating and set a $75.00 price target (down previously from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. UBS Group cut their price target on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a report on Wednesday, August 6th. Finally, Barrington Research decreased their price objective on shares of Henry Schein from $86.00 to $78.00 and set an “outperform” rating for the company in a report on Wednesday, August 6th. Four research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $75.58.

Henry Schein Price Performance

NASDAQ HSIC opened at $68.31 on Wednesday. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The company has a fifty day simple moving average of $70.67 and a 200 day simple moving average of $70.61. The company has a market cap of $8.28 billion, a P/E ratio of 22.04, a P/E/G ratio of 2.22 and a beta of 0.81. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same period in the prior year, the company posted $1.23 earnings per share. Henry Schein’s quarterly revenue was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, sell-side analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.